111 related articles for article (PubMed ID: 1967074)
1. p-Fluoro-hexahydro-sila-difenidol exhibits poor selectivity between M3 and M1 muscarinic receptors.
Meng Y; Hu J; el-Fakahany EE
Membr Biochem; 1990; 9(4):293-300. PubMed ID: 1967074
[TBL] [Abstract][Full Text] [Related]
2. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
[TBL] [Abstract][Full Text] [Related]
3. Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects.
Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
Eur J Pharmacol; 1991 Feb; 206(2):95-103. PubMed ID: 2065719
[TBL] [Abstract][Full Text] [Related]
4. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.
Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G
Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol and related selective muscarinic antagonists.
Lambrecht G; Feifel R; Moser U; Wagner-Röder M; Choo LK; Camus J; Tastenoy M; Waelbroeck M; Strohmann C; Tacke R
Trends Pharmacol Sci; 1989 Dec; Suppl():60-4. PubMed ID: 2694525
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors.
Smith CM; Wallis RM
J Recept Signal Transduct Res; 1997; 17(1-3):177-84. PubMed ID: 9029489
[TBL] [Abstract][Full Text] [Related]
7. Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M1, cardiac M2, pancreatic M3, and striatum M4 muscarinic receptors.
Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
Chirality; 1991; 3(2):118-23. PubMed ID: 1863523
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland.
Barras M; Coste A; Eon MT; Guillot E
Fundam Clin Pharmacol; 1999; 13(5):562-70. PubMed ID: 10520729
[TBL] [Abstract][Full Text] [Related]
11. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
[TBL] [Abstract][Full Text] [Related]
12. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
Miller JH; Aagaard PJ; Gibson VA; McKinney M
J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
[TBL] [Abstract][Full Text] [Related]
13. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the central muscarinic cholinoceptors involved in the cholinergic pressor response in anesthetized dogs.
Pelat M; Lazartigues E; Tran MA; Gharib C; Montastruc JL; Montastruc P; Rascol O
Eur J Pharmacol; 1999 Aug; 379(2-3):117-24. PubMed ID: 10497897
[TBL] [Abstract][Full Text] [Related]
15. M1 and M3 muscarinic receptors: specific roles in sleep regulation.
Imeri L; Bianchi S; Angeli P; Mancia M
Neuroreport; 1992 Mar; 3(3):276-8. PubMed ID: 1515585
[TBL] [Abstract][Full Text] [Related]
16. Interaction of p-F-HHSiD (p-Fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea.
Eglen RM; Cornett CM; Whiting RL
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):394-9. PubMed ID: 2255333
[TBL] [Abstract][Full Text] [Related]
17. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
[TBL] [Abstract][Full Text] [Related]
18. Selective labelling of muscarinic M1 receptors in calf superior cervical ganglia by [3H](+/-)-telenzepine.
Feifel R; Rodrigues de Miranda JF; Strohmann C; Tacke R; Aasen AJ; Mutschler E; Lambrecht G
Eur J Pharmacol; 1991 Mar; 195(1):115-23. PubMed ID: 2065706
[TBL] [Abstract][Full Text] [Related]
19. Pressor response to posterior hypothalamic administration of carbachol is mediated by muscarinic M3 receptor.
Martin JR
Eur J Pharmacol; 1992 Apr; 215(1):83-91. PubMed ID: 1516652
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta.
Jaiswal N; Lambrecht G; Mutschler E; Tacke R; Malik KU
J Pharmacol Exp Ther; 1991 Sep; 258(3):842-50. PubMed ID: 1716312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
